Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaski

Showing results (951-960 of 1,021) with videos related to

Pageof 103
Sort By:
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 31, 2024
Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance EndpointsValentina O Puntmann, Dietrich Beitzke, Andreas Kammerlander, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyGiuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 9, 2022
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registryLuis R Lopes, Maria-Angela Losi, Nabeel Sheikh, et al.
Current Opinion in Neurology|June 17, 2026
Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and interventionAasef G Shaikh, Chrystalina Antoniades, Qadeer Arshad, et al.
ESC Heart Failure|September 17, 2020
Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of CardiologyKatarzyna Mizia-Stec, Alida L P Caforio, Philippe Charron, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 31, 2021
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma F Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal|March 5, 2024
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidenceNabil V Sayour, Ágnes M Paál, Pietro Ameri, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma Forton Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal|May 26, 2021
Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) GroupHiroaki Shimokawa, Akira Suda, Jun Takahashi, et al.
ESC Heart Failure|August 9, 2020
ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patientsTiina Heliö, Perry Elliott, Juha W Koskenvuo, et al.
Pageof 103

Showing results (951-960 of 1,021) with videos related to

Sort By:
Pageof 103
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 31, 2024
Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance EndpointsValentina O Puntmann, Dietrich Beitzke, Andreas Kammerlander, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 5, 2018
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyGiuseppe M C Rosano, Juan Tamargo, Keld P Kjeldsen, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 9, 2022
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registryLuis R Lopes, Maria-Angela Losi, Nabeel Sheikh, et al.
Current Opinion in Neurology|June 17, 2026
Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and interventionAasef G Shaikh, Chrystalina Antoniades, Qadeer Arshad, et al.
ESC Heart Failure|September 17, 2020
Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of CardiologyKatarzyna Mizia-Stec, Alida L P Caforio, Philippe Charron, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 31, 2021
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma F Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal|March 5, 2024
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidenceNabil V Sayour, Ágnes M Paál, Pietro Ameri, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma Forton Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal|May 26, 2021
Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) GroupHiroaki Shimokawa, Akira Suda, Jun Takahashi, et al.
ESC Heart Failure|August 9, 2020
ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patientsTiina Heliö, Perry Elliott, Juha W Koskenvuo, et al.
Pageof 103